These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 5539358)

  • 1. Changes in spontaneous fibrinolytic activity during use of oral contraceptives.
    Hedlin AM; Monkhouse FC
    Obstet Gynecol; 1971 Feb; 37(2):225-32. PubMed ID: 5539358
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of oral contraceptive estrogen on blood coagulation and fibrinolysis.
    Hedlin AM
    Thromb Diath Haemorrh; 1975 Apr; 33(2):370-8. PubMed ID: 1138426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Blood coagulation during treatment with oral contraceptives].
    Bailo U; Finzi C
    Minerva Ginecol; 1968 Dec; 20(23):1879-84. PubMed ID: 5734792
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical hypercoagulability and oral contraceptives.
    von Kaulla E; von Kaulla KN; Droegemueller W
    Rocky Mt Med J; 1972 Jun; 69(6):33-6. PubMed ID: 5031944
    [No Abstract]   [Full Text] [Related]  

  • 5. Progestational agents and blood coagulation. II.
    Ambrus JL; Niswander KR; Courey NG; Wamsteker EF; Mink IB
    Am J Obstet Gynecol; 1969 Apr; 103(7):994-1001. PubMed ID: 5774681
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of changes in activity of some hemocoagulation factors during contraception and therapy with combinations of synthetic steroids with varied gestagenic components].
    Misinger I; Hermanská Z
    Cas Lek Cesk; 1971 Feb; 110(9):196-9. PubMed ID: 5547223
    [No Abstract]   [Full Text] [Related]  

  • 7. [Blood coagulation and fibrinolysis in patients treated with an anovulatory drug with estroprogestational action].
    Schubert L; Gibelli A; De Nicola P
    Ann Ostet Ginecol Med Perinat; 1968 Jan; 90(1):48-58. PubMed ID: 5739142
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of oral contraceptives on factor VIII levels.
    Crowell EB; Clatanoff DV; Kiekhofer W
    J Lab Clin Med; 1971 Apr; 77(4):551-7. PubMed ID: 5554340
    [No Abstract]   [Full Text] [Related]  

  • 9. [Side effects of the oral contraceptive Ovosiston on the blood coagulation system].
    Carol W; Klinger G; Hempel E; Starker K; Quent P
    Zentralbl Gynakol; 1970 Dec; 92(50):1641-50. PubMed ID: 4099364
    [No Abstract]   [Full Text] [Related]  

  • 10. Hormonal contraception and thromboembolic disease: effects of the oral contraceptives on hemostatic mechanisms. A review of the literature.
    Dugdale M; Masi AT
    J Chronic Dis; 1971 Mar; 23(10):775-90. PubMed ID: 4933752
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral contraceptives, blood clotting and thrombosis.
    Poller L
    Br Med Bull; 1978 May; 34(2):151-6. PubMed ID: 350338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oestro-progestogenic oral contraceptives on blood coagulation, fibrinolysis, and platelet aggregation.
    Ghezzo F; Mele A; Pegoraro L
    Haematologica; 1980 Dec; 65(6):737-45. PubMed ID: 6790364
    [No Abstract]   [Full Text] [Related]  

  • 13. Blood clotting and the pill.
    Br Med J; 1972 Nov; 4(5837):378-9. PubMed ID: 4118011
    [No Abstract]   [Full Text] [Related]  

  • 14. Antithrombin 3 depression and thrombin generation acceleration in women taking oral contraceptives.
    Von Kaulla E; Droegemueller W; Aoki N; Von Kaulla KN
    Am J Obstet Gynecol; 1971 Mar; 109(6):868-73. PubMed ID: 5552623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conjugated estrogens and hypercoagulability.
    von Kaulla E; Droegemueller W; von Kaulla KN
    Am J Obstet Gynecol; 1975 Jul; 122(6):688-92. PubMed ID: 168774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship of clotting factors to dosage levels of estrogen and progestogen-like combinations.
    Banks AL; Rutherford RN; Coburn WA; Welsh RL
    Int J Fertil; 1966; 11(3):277-80. PubMed ID: 5967993
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antithrombin 3 changes in women using oral contraceptives].
    Conard J; Salomon Y; Samama M
    Pathol Biol (Paris); 1974 Jan; 22(1):77-80. PubMed ID: 4592416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboembolic complications of oral contraceptive therapy.
    Ambrus JL; Mink IB; Courey NG; Niswander K; Moore RH; Ambrus CM; Lillie MA
    Res Commun Chem Pathol Pharmacol; 1975 Jan; 10(1):197-200. PubMed ID: 1124318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental data on the existence and significance of an anticoagulating system in fish].
    Kudriashov BA; Kalishevskaia TM; Bazaz'ian GG; Volkov VN
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1974; 2():31-6. PubMed ID: 4824513
    [No Abstract]   [Full Text] [Related]  

  • 20. The haemostatic mechanism in oral contraception.
    Hilden M; Amris CJ; Starup J
    Acta Obstet Gynecol Scand; 1967; 46(4):562-71. PubMed ID: 6082549
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.